The US Food and Drug Administration has formally approved Abbott's two new over-the-counter continuous glucose monitoring (CGM) systems in Lingo™ and Libre Rio™. Based...
The US Food and Drug Administration has officially given its approval to Abbott's Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), which...
